These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 22879865)

  • 1. Functional analysis of two PLA2G2A variants associated with secretory phospholipase A2-IIA levels.
    Exeter HJ; Folkersen L; Palmen J; Franco-Cereceda A; Cooper JA; Kalea AZ; Hooft FV; Eriksson P; Humphries SE; Talmud PJ
    PLoS One; 2012; 7(7):e41139. PubMed ID: 22879865
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The association of PLA2G2A single nucleotide polymorphisms with type IIa secretory phospholipase A2 level but not its activity in patients with stable coronary heart disease.
    Shuvalova YA; Khasanova ZB; Kaminnaya VI; Samoilova EV; Korotaeva AA; Rubanovich AV; Kaminnyi AI
    Gene; 2015 Jun; 564(1):29-34. PubMed ID: 25794429
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of 5'UTR polymorphism of secretory phospholipase A2 group IIA (PLA2G2A) gene with prostate cancer metastasis.
    Ozturk K; Onal MS; Efiloglu O; Nikerel E; Yildirim A; Telci D
    Gene; 2020 Jun; 742():144589. PubMed ID: 32179174
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Secretory phospholipase A(2)-IIA and cardiovascular disease: a mendelian randomization study.
    Holmes MV; Simon T; Exeter HJ; Folkersen L; Asselbergs FW; Guardiola M; Cooper JA; Palmen J; Hubacek JA; Carruthers KF; Horne BD; Brunisholz KD; Mega JL; van Iperen EPA; Li M; Leusink M; Trompet S; Verschuren JJW; Hovingh GK; Dehghan A; Nelson CP; Kotti S; Danchin N; Scholz M; Haase CL; Rothenbacher D; Swerdlow DI; Kuchenbaecker KB; Staines-Urias E; Goel A; van 't Hooft F; Gertow K; de Faire U; Panayiotou AG; Tremoli E; Baldassarre D; Veglia F; Holdt LM; Beutner F; Gansevoort RT; Navis GJ; Mateo Leach I; Breitling LP; Brenner H; Thiery J; Dallmeier D; Franco-Cereceda A; Boer JMA; Stephens JW; Hofker MH; Tedgui A; Hofman A; Uitterlinden AG; Adamkova V; Pitha J; Onland-Moret NC; Cramer MJ; Nathoe HM; Spiering W; Klungel OH; Kumari M; Whincup PH; Morrow DA; Braund PS; Hall AS; Olsson AG; Doevendans PA; Trip MD; Tobin MD; Hamsten A; Watkins H; Koenig W; Nicolaides AN; Teupser D; Day INM; Carlquist JF; Gaunt TR; Ford I; Sattar N; Tsimikas S; Schwartz GG; Lawlor DA; Morris RW; Sandhu MS; Poledne R; Maitland-van der Zee AH; Khaw KT; Keating BJ; van der Harst P; Price JF; Mehta SR; Yusuf S; Witteman JCM; Franco OH; Jukema JW; de Knijff P; Tybjaerg-Hansen A; Rader DJ; Farrall M; Samani NJ; Kivimaki M; Fox KAA; Humphries SE; Anderson JL; Boekholdt SM; Palmer TM; Eriksson P; Paré G; Hingorani AD; Sabatine MS; Mallat Z; Casas JP; Talmud PJ
    J Am Coll Cardiol; 2013 Nov; 62(21):1966-1976. PubMed ID: 23916927
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PLA2G2A polymorphisms are associated with metabolic syndrome and type 2 diabetes mellitus. Results from the genetics of atherosclerotic disease Mexican study.
    Monroy-Muñoz IE; Angeles-Martinez J; Posadas-Sánchez R; Villarreal-Molina T; Alvarez-León E; Flores-Dominguez C; Cardoso-Saldaña G; Medina-Urrutia A; Juárez-Rojas JG; Posadas-Romero C; Alarcon GV
    Immunobiology; 2017 Oct; 222(10):967-972. PubMed ID: 27608594
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tagging SNP haplotype analysis of the secretory PLA2-V gene, PLA2G5, shows strong association with LDL and oxLDL levels, suggesting functional distinction from sPLA2-IIA: results from the UDACS study.
    Wootton PT; Arora NL; Drenos F; Thompson SR; Cooper JA; Stephens JW; Hurel SJ; Hurt-Camejo E; Wiklund O; Humphries SE; Talmud PJ
    Hum Mol Genet; 2007 Jun; 16(12):1437-44. PubMed ID: 17545304
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of single nucleotide polymorphisms in the prostaglandin-endoperoxide synthase 2 (PTGS2) and phospholipase A₂ group IIA (PLA2G2A) genes with susceptibility to esophageal squamous cell carcinoma.
    Liu F; Wei WQ; Cormier RT; Zhang ST; Qiao YL; Li XQ; Zhu ST; Zhai YC; Peng XX; Yan YX; Wu LJ; He D; He Y
    Asian Pac J Cancer Prev; 2014; 15(4):1797-802. PubMed ID: 24641411
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Promoting effect of hepatitis B virus on the expressoin of phospholipase A2 group IIA.
    Zhu C; Song H; Shen B; Wu L; Liu F; Liu X
    Lipids Health Dis; 2017 Jan; 16(1):5. PubMed ID: 28077172
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Type II secretory phospholipase A2 and prognosis in patients with stable coronary heart disease: mendelian randomization study.
    Breitling LP; Koenig W; Fischer M; Mallat Z; Hengstenberg C; Rothenbacher D; Brenner H
    PLoS One; 2011; 6(7):e22318. PubMed ID: 21799821
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Group IIA Secretory Phospholipase A
    Akinkuolie AO; Lawler PR; Chu AY; Caulfield M; Mu J; Ding B; Nyberg F; Glynn RJ; Ridker PM; Hurt-Camejo E; Chasman DI; Mora S
    Arterioscler Thromb Vasc Biol; 2019 Jun; 39(6):1182-1190. PubMed ID: 31070471
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The roles of sPLA2-IIA (Pla2g2a) in cancer of the small and large intestine.
    Fijneman RJ; Cormier RT
    Front Biosci; 2008 May; 13():4144-74. PubMed ID: 18508504
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Secretory phospholipase A
    Kuefner MS; Deng X; Stephenson EJ; Pham K; Park EA
    FASEB J; 2019 Jan; 33(1):738-749. PubMed ID: 30020829
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thyroid hormone status regulates the expression of secretory phospholipases.
    Sharma P; Levesque T; Boilard E; Park EA
    Biochem Biophys Res Commun; 2014 Jan; 444(1):56-62. PubMed ID: 24440706
    [TBL] [Abstract][Full Text] [Related]  

  • 14. AMPK Signaling Involvement for the Repression of the IL-1β-Induced Group IIA Secretory Phospholipase A2 Expression in VSMCs.
    El Hadri K; Denoyelle C; Ravaux L; Viollet B; Foretz M; Friguet B; Rouis M; Raymondjean M
    PLoS One; 2015; 10(7):e0132498. PubMed ID: 26162096
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Secretory phospholipase A2, group IIA is a novel serum amyloid A target gene: activation of smooth muscle cell expression by an interleukin-1 receptor-independent mechanism.
    Sullivan CP; Seidl SE; Rich CB; Raymondjean M; Schreiber BM
    J Biol Chem; 2010 Jan; 285(1):565-75. PubMed ID: 19850938
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Secretory phospholipase A
    Kuefner MS; Pham K; Redd JR; Stephenson EJ; Harvey I; Deng X; Bridges D; Boilard E; Elam MB; Park EA
    J Lipid Res; 2017 Sep; 58(9):1822-1833. PubMed ID: 28663239
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of secretory phospholipase A2 in colon tumor cells potentiates tumor growth.
    Belinsky GS; Rajan TV; Saria EA; Giardina C; Rosenberg DW
    Mol Carcinog; 2007 Feb; 46(2):106-16. PubMed ID: 17091473
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Knockdown of secretory phospholipase A2 IIa reduces lung cancer growth in vitro and in vivo.
    Yu JA; Mauchley D; Li H; Meng X; Nemenoff RA; Fullerton DA; Weyant MJ
    J Thorac Cardiovasc Surg; 2012 Nov; 144(5):1185-91. PubMed ID: 23079010
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of group IIA phospholipase A2 is an independent predictor of favorable outcome for patients with gastric cancer.
    Wang X; Huang CJ; Yu GZ; Wang JJ; Wang R; Li YM; Wu Q
    Hum Pathol; 2013 Oct; 44(10):2020-7. PubMed ID: 23664539
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of type IIA secretory phospholipase A2 inhibits cholesteryl ester transfer protein activity in transgenic mice.
    Hurt-Camejo E; Gautier T; Rosengren B; Dikkers A; Behrendt M; Grass DS; Rader DJ; Tietge UJ
    Arterioscler Thromb Vasc Biol; 2013 Dec; 33(12):2707-14. PubMed ID: 24115030
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.